Glucosamine and Fosaprepitant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucosamine (glucosamine) and Fosaprepitant (fosaprepitant). Common drug interactions include blister among females.

The phase IV clinical study analyzes what interactions people have when they take Glucosamine and Fosaprepitant. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Glucosamine?

Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.

What is Fosaprepitant?

Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.



On Jul, 26, 2026

24 people who take Glucosamine and Fosaprepitant together, and have interactions are studied.

Glucosamine and Fosaprepitant drug interactions.

What are the common drug interactions of Glucosamine and Fosaprepitant, by gender? *:

female:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Decreased appetite
  3. Night sweats (sweating in night)
  4. Oedema (fluid collection in tissue)
  5. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  6. Hand deformity
  7. Wound
  8. Abdominal discomfort
  9. Anxiety
  10. Asthma

male:

n/a

What are the common drug interactions of Glucosamine and Fosaprepitant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Alopecia (absence of hair from areas of the body)
  3. Decreased appetite
  4. Delirium (wild excitement)
  5. Hypertension (high blood pressure)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Ill-defined disorder
  8. Dizziness
  9. Drug hypersensitivity
  10. Dry mouth

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 100.00%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 23 people, 95.83%
  3. Psoriasis (immune-mediated disease that affects the skin): 14 people, 58.33%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 58.33%
  5. Stress And Anxiety: 5 people, 20.83%
  6. Inflammation: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine and Fosaprepitant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glucosamine and Fosaprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glucosamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fosaprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucosamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosaprepitant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine and fosaprepitant (the active ingredients of Glucosamine and Fosaprepitant, respectively), and Glucosamine and Fosaprepitant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: